Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference
Rhea-AI Summary
Prestige Consumer Healthcare (NYSE:PBH) announced that CFO and COO Christine Sacco and VP Investor Relations, Treasury & Business Development Phil Terpolilli will join a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026 at 10:00 a.m. ET. A live webcast and replay will be accessible via the company’s investor relations website.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 06 | Fiscal Q1 earnings | Positive | +2.7% | Revenue growth, higher adjusted EPS, and raised fiscal 2027 guidance |
| Jul 06 | Acquisition and notes | Negative | -1.1% | LaCorium acquisition closed alongside $400 million senior notes issuance |
| Jun 30 | Senior notes offering | Negative | -1.6% | Company announced up to $400 million of senior unsecured notes |
| Jun 15 | Brand acquisition | Positive | -2.4% | Company completed the $1.045 billion Breathe Right brand acquisition |
| Jun 05 | Conference participation | Neutral | +3.8% | Company announced participation in an Oppenheimer virtual fireside chat |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Historical reactions were mixed: the prior earnings report and notes offering aligned with price direction, while the acquisition and conference announcements diverged.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TARRYTOWN, N.Y., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Christine Sacco, CFO and COO, and Phil Terpolilli, VP, Investor Relations, Treasury, & Business Development will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on Wednesday August 12, 2026 at 10:00 a.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:
https://ir.prestigebrands.com/events-presentations/events
For those unable to participate during the live webcast, a replay option will be available on the Company’s website following the event.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Breathe Right® nasal strips, Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, as well as Hydralyte® rehydration products and the Dermal Therapy® line of therapeutic skin care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact Phil Terpolilli, CFA, 914-524-6819 irinquiries@prestigebrands.com